145 related articles for article (PubMed ID: 7809904)
1. Autoimmune diseases as stem cell disorders.
Ikehara S; Inaba M; Yasumizu R; Nagata N; Toki J; Hisha H; Sugiura K; Oyaizu N; Kawamura M; Than S
Tohoku J Exp Med; 1994 May; 173(1):141-55. PubMed ID: 7809904
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation for autoimmune diseases.
Ikehara S
Acta Haematol; 1998; 99(3):116-32. PubMed ID: 9587393
[TBL] [Abstract][Full Text] [Related]
3. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
Good RA
World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation: a new strategy for intractable diseases.
Ikehara S
Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
[TBL] [Abstract][Full Text] [Related]
5. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation.
Ikehara S; Yasumizu R; Inaba M; Izui S; Hayakawa K; Sekita K; Toki J; Sugiura K; Iwai H; Nakamura T
Proc Natl Acad Sci U S A; 1989 May; 86(9):3306-10. PubMed ID: 2654943
[TBL] [Abstract][Full Text] [Related]
6. Distinct qualitative differences between normal and abnormal hemopoietic stem cells in vivo and in vitro.
Kawamura M; Hisha H; Li Y; Fukuhara S; Ikehara S
Stem Cells; 1997; 15(1):56-62. PubMed ID: 9007223
[TBL] [Abstract][Full Text] [Related]
7. New strategies for BMT, organ transplantation, and regeneration therapy.
Ikehara S
Hematology; 2003 Apr; 8(2):77-81. PubMed ID: 12745656
[TBL] [Abstract][Full Text] [Related]
8. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells.
Ikehara S; Kawamura M; Takao F; Inaba M; Yasumizu R; Than S; Hisha H; Sugiura K; Koide Y; Yoshida TO
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8341-4. PubMed ID: 2236044
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune diseases as stem cell disorders: normal stem cell transplant for their treatment (Review).
Ikehara S
Int J Mol Med; 1998 Jan; 1(1):5-16. PubMed ID: 9852193
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
[TBL] [Abstract][Full Text] [Related]
11. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice.
Kushida T; Inaba M; Hisha H; Ichioka N; Esumi T; Ogawa R; Iida H; Ikehara S
Blood; 2001 May; 97(10):3292-9. PubMed ID: 11342461
[TBL] [Abstract][Full Text] [Related]
12. Treatment of systemic and organ-specific autoimmune disease in mice by allogeneic bone marrow transplantation.
Ikehara S; Nakamura T; Sekita K; Muso E; Yasumizu R; Ohtsuki H; Hamashima Y; Good RA
Prog Clin Biol Res; 1987; 229():131-46. PubMed ID: 3299389
[TBL] [Abstract][Full Text] [Related]
13. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
[TBL] [Abstract][Full Text] [Related]
14. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor.
Ishida T; Inaba M; Hisha H; Sugiura K; Adachi Y; Nagata N; Ogawa R; Good RA; Ikehara S
J Immunol; 1994 Mar; 152(6):3119-27. PubMed ID: 8144907
[TBL] [Abstract][Full Text] [Related]
15. Treatment of autoimmune diseases in mice by a new method for allogeneic bone marrow transplantation.
Ikehara S
Ther Apher Dial; 2003 Jun; 7(3):292-7. PubMed ID: 12924603
[TBL] [Abstract][Full Text] [Related]
16. Rationale for bone marrow transplantation in the treatment of autoimmune diseases.
Ikehara S; Good RA; Nakamura T; Sekita K; Inoue S; Oo MM; Muso E; Ogawa K; Hamashima Y
Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2483-7. PubMed ID: 3887403
[TBL] [Abstract][Full Text] [Related]
17. The characteristics of hematopoietic stem cells from autoimmune-prone mice and the role of neural cell adhesion molecules in abnormal proliferation of these cells in MRL/lpr mice.
Wang X; Hisha H; Cui W; Song C; Mizokami T; Okazaki S; Li Q; Feng W; Kato J; Jiang S; Fan H; Ikehara S
Haematologica; 2007 Mar; 92(3):300-7. PubMed ID: 17339178
[TBL] [Abstract][Full Text] [Related]
18. The future of stem cell transplantation in autoimmune disease.
Ikehara S
Clin Rev Allergy Immunol; 2010 Apr; 38(2-3):292-7. PubMed ID: 19609732
[TBL] [Abstract][Full Text] [Related]
19. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
[TBL] [Abstract][Full Text] [Related]
20. Analyses of thymic abnormalities in autoimmune-prone (NZW x BXSB) F1 mice.
Adachi Y; Inaba M; Inaba K; Than S; Kobayashi Y; Ikehara S
Immunobiology; 1993 Aug; 188(4-5):340-54. PubMed ID: 8244442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
